| 1 |
33415416 | Concentration-QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia. | 2021 Apr |
3 |
| 2 |
32598495 | Population Pharmacokinetic Analysis of Quizartinib in Healthy Volunteers and Patients With Relapsed/Refractory Acute Myeloid Leukemia. | 2020 Dec |
2 |
| 3 |
32683457 | Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia. | 2020 Sep |
2 |
| 4 |
30898762 | Role of CYP3A4 in bone marrow microenvironment-mediated protection of FLT3/ITD AML from tyrosine kinase inhibitors. | 2019 Mar 26 |
1 |
| 5 |
31173645 | Effects of CYP3A inhibitors on the pharmacokinetics of quizartinib, a potent and selective FLT3 inhibitor, and its active metabolite. | 2019 Sep |
2 |